Focus-X Therapeutics is a preclinical-stage biotechnology company focused on the radiopharmaceutical pipeline. They focus on unmet needs in cancer diagnosis and therapy by applying our theragnostic approach to solid tumors with a very low five-year survival rate. It brings its proprietary radioligand therapy (RLT) to precisely deliver alpha orbeta emitters to break down cancer cell DNA.

Biotechnology

Focus-X Therapeutics, Inc.

Focus-X Therapeutics, Inc.'s headquarters in Sammamish, WA, United States

Description

People

Jobs